<html xmlns:fn="http://www.w3.org/2005/xpath-functions" xmlns:xs="http://www.w3.org/2001/XMLSchema">

<body onload="start();">
    <p>1.	Yamagata, K., et al. (1998). Mutation P291fsinsC in the transcription factor hepatocyte nuclear factor-la is dominant negative. Diabetes. 47: 1231-1235.</p>
    <p>2.	Ellard, S. (2000). Hepatocyte nuclear factor 1 alpha (HNF-1 alpha) mutations in maturity-onset diabetes of the young. Human Mutation. 16(5):377-85.</p>
    <p>3.	Kaisaki, P.J., et al. (1997). Mutations in the hepatocyte nuclear factor-1a gene in MODY and early-onset NIDDM: Evidence for a mutational hotspot in exon 4. Diabetes. 46: 528-535.</p>
    <p>4.	Yamada, S., et al. (1997). Identification of mutations in the hepatocyte nuclear factor (HNF)-la gene in Japanese subjects with IDDM. Diabetes. 46(10): 1643-1647.</p>
    <p>5.	Bjorkhaug, L., et al. (2003). Hepatocyte nuclear factor-1 alpha gene mutations and diabetes in Norway. J Clin Endocrinol Metab. 88(2):920-31.</p>
    <p>6.	Frayling, T.M., et al. (1997). A rapid screening method for hepatocyte nuclear factor 1 alpha frameshift mutations; prevalence in maturity-onset diabetes of the young and late-onset non-insulin dependent diabetes. Human Genetics. 101(3):351-4.</p>
    <p>7.	Yamagata, K., et al. (1996). Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3). Nature. 384(6608): 455-458.</p>
    <p>8.	Vaxillarie, M., et al. (1999). Autonomy of a homeoprotein revealed by the analysis of human MODY3 mutations. J Biological Chemistry.  274: 35639-35646.</p>
    <p>9.  Rubio-Cabezas, O., et al. (2014). International Society for Pediatric and Adolescent Diabetes. ISPAD Clinical Practice Consensus Guidelines 2014. The diagnosis and management of monogenic diabetes in children and adolescents. Pediatric Diabetes. 15 (Suppl 20):47-64.</p>
</body>
</html>

